• Influenza Hemagglutinin (HA) Peptide in Mechanistic IP

  2026-09-21

  Learn how the Influenza Hemagglutinin (HA) Peptide converts HA-tagged immunoprecipitation into a controlled mechanistic experiment. This guide connects competitive elution design with the NEDD4L–PRMT5–AKT/mTOR findings in colorectal cancer research.

• Alternariol, LX-2 Cells, and Liver Fibrosis

  2026-09-21

  The reference study shows that Alternariol (AOH) and alternariol monomethyl ether can drive LX-2 hepatic stellate cells toward a contractile, extracellular-matrix-producing myofibroblast state, whereas tenuazonic acid produced no comparable response in this model. By integrating lncRNA–mRNA omics with pathway and phenotype analyses, the work connects Alternaria toxin exposure to NF-κB signaling, ferroptosis, autophagy, and a preliminary CotA laccase detoxification strategy.

• Acetylcysteine in Redox-Aware Cancer Research

  2026-09-20

  Acetylcysteine is more than a generic antioxidant: it is a mechanistic perturbation tool for separating glutathione, ROS, and disulfide-dependent effects. This article connects N-acetyl-L-cysteine assay design with nanomedicine, immune remodeling, hepatic protection, and respiratory research.

• MRT68921: A Mechanistic Guide to ULK1/2 Blockade

  2026-09-19

  MRT68921 is a potent ULK1 kinase inhibitor and dual ULK1/2 tool for dissecting autophagy initiation. This guide connects ATG13 phosphorylation blockade and LC3 flux measurement with lipid-autophagy assay design, emphasizing interpretation, controls, and translational limits.

• Thiazovivin (A5506): ROCK Inhibitor Workflow

  2026-09-19

  Thiazovivin is a ROCK inhibitor used to support fibroblast reprogramming and improve human embryonic stem cell survival after handling steps such as trypsinization. This article provides product-specific preparation and workflow guidance while emphasizing that concentration, exposure time, and suitability must be validated for each cell model and that the compound is not intended for diagnostic, clinical, or therapeutic use.

• HBsAg Redirects TBK1 to Silence IFN and Trigger Autophagy

  2026-09-18

  The 2025 Cell Death and Disease study identifies a mechanism by which hepatitis B surface antigen redirects TBK1 activity away from IRF3-dependent interferon production and toward p62-associated autophagy. By combining interaction studies, pharmacological perturbation, HBV models, transgenic mice, and human liver samples, the work links innate immune suppression, incomplete autophagy, and viral persistence.

• Methicillin Sodium Salt for MSSA Assays

  2026-09-17

  Build reproducible MSSA susceptibility, time-kill, and gram-positive infection workflows with a mechanistically defined β-lactam benchmark. This guide also shows how the EAGLE-2 and EAGLE-3 trial design can inspire stronger endpoint selection without confusing clinical UTI evidence with methicillin activity.

• Palonosetron for Delayed CINV: Evidence Update

  2026-09-17

  This review evaluates palonosetron hydrochloride as a long-acting 5-HT3 receptor antagonist for radio- and chemotherapy-induced nausea and vomiting, emphasizing its distinctive receptor affinity and sustained activity against delayed CINV after moderately emetogenic chemotherapy. Its main practical contribution is linking pharmacology with antiemetic guidelines while identifying unresolved questions involving multiple-day treatment, breakthrough symptoms, and combination therapy.

• T7 RNA Polymerase for RNA Therapeutic Workflows

  2026-09-17

  Build reproducible RNA workflows for mRNA, probes, ribozymes, and RNAi using a promoter-specific transcription system. This guide connects template design and quality control with the inhaled RNA strategy reported for remodeling the lung tumor microenvironment.

• EGCG Nanoparticles Enhance FLASH-RT Antitumor Effects

  2026-09-16

  A 2026 International Journal of Nanomedicine study developed functionalized self-assembled EGCG nanoparticles (BENPs) to sensitize 4T1 tumors to FLASH radiotherapy. The combination increased radiation-associated ROS and DNA damage while also promoting antitumor immune responses, providing a mechanistic framework for improving FLASH-RT without simply escalating radiation exposure.

• GDC-0068 (RG7440) Workflow for Akt–mTOR Assays

  2026-09-15

  GDC-0068 (RG7440) provides a selective pan-AKT perturbation strategy for linking PI3K/Akt/mTOR signaling to phosphorylation, proliferation, cell-cycle behavior, and tumor-cell survival. Its greatest value emerges when acute pathway assays are paired with spatially targeted mTORC1 tools to distinguish global Akt dependence from compartment-specific signaling.

• DAPI (hydrochloride) Workflows for DNA Analysis

  2026-09-15

  DAPI (hydrochloride) combines sequence-biased nuclear labeling with practical utility in microscopy, flow cytometry, chromosome staining, and infection-model readouts. This guide translates its chemistry into reproducible workflows for fixed and live cells, including an assay framework inspired by erythrocyte-mimicking nanovesicles targeting Porphyromonas gingivalis.

• Dual HER2–VEGFR-2 Targeting in TNBC

  2026-09-14

  The 2026 reference study evaluates Lapatinib and Telatinib as a dual tyrosine kinase inhibition strategy in HER2-negative MDA-MB-231 triple-negative breast cancer cells. Its phenotype-first findings connect treatment with reduced invadopodia formation, cell proliferation, and two-dimensional tube formation, while emphasizing that functional response does not by itself prove direct HER2 engagement.

• O-GlcNAcylation Rewires Wnt-Driven Bone Formation

  2026-09-14

  The reference study identifies O-GlcNAcylation as a necessary metabolic mediator of Wnt-stimulated osteogenesis rather than a passive consequence of increased glucose flux. Its central mechanism links Wnt3a to PDK1 Ser174 modification, PDK1 stabilization, enhanced aerobic glycolysis, and bone formation, with implications for fracture repair and anabolic osteoporosis research.

• MitMAB for Organoid Endocytosis Research

  2026-09-13

  MitMAB provides a practical way to test whether extracellular-vesicle uptake depends on dynamin-driven vesicle scission. In polarized intestinal organoids, it helps connect uptake measurements with epithelial orientation, regional biology, barrier status, and intracellular trafficking research.

8735 records 1/583 page Next 12345 下5页 Last page